ProShare Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

ProShare Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,112	Closed	-$219K	–	1663
2020 Q2	$219K	Sell	1,112 -8	-0.7%	-$1.66K	﹤0.01%	1409
2020 Q1	$219K	Sell	1,120 -636	-36%	-$137K	﹤0.01%	975
2019 Q4	$363K	Sell	1,756 -535	-23%	-$98.9K	﹤0.01%	1238
2019 Q3	$350K	Sell	2,291 -237	-9%	-$38.8K	﹤0.01%	1144
2019 Q2	$326K	Sell	2,528 -533	-17%	-$63.2K	﹤0.01%	1196
2019 Q1	$361K	Sell	3,061 -529	-15%	-$53.3K	﹤0.01%	1166
2018 Q4	$329K	Sell	3,590 -13	-0.4%	-$1.32K	﹤0.01%	1100
2018 Q3	$405K	Sell	3,603 -631	-15%	-$66.7K	﹤0.01%	1204
2018 Q2	$390K	Sell	4,234 -730	-15%	-$70.8K	﹤0.01%	1235
2018 Q1	$495K	Sell	4,964 -911	-16%	-$98.2K	﹤0.01%	1098
2017 Q4	$551K	Buy	+5,875	New	+$556K	﹤0.01%	1086

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

ProShare Advisors's LKFT Position: Q3 2020 in Review

ProShare Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 1,112 shares — an estimated $219K sold.

ProShare Advisors first reported a position in LKFT in Q4 2017 and held it in 11 quarters. The position peaked at $551K in Q4 2017. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

ProShare Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
ProShare Advisors sold 1,112 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $219K.
ProShare Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2017 and held it in 11 quarters.
ProShare Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $551K in Q4 2017.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on ProShare Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.